FOLH1 and neoplasm: Hence, the effect of palbociclib and fulvestrant on bsAb- or UniCAR T cell-mediated tumor cell killing was investigated by performing luminescence-based killing assays with LNCaP-PSCA Luc+ or PC3-PSCA/PSMA Luc+ cells.